• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Medidata, Peking University expand partnership in China

Medidata, Peking University expand partnership in China

April 15, 2015
CenterWatch Staff

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, has expanded its partnership with Peking University Clinical Research Institute (PUCRI), an academic center dedicated to enhancing the development of high-quality clinical research and health innovation in China. Leveraging the research institute’s extensive clinical development network, experience and resources, the partnership will accelerate the adoption of the Medidata Clinical Cloud platform across China and, in doing so, optimize local drug development programs by bringing operational efficiencies and greater speed to clinical trials.

Weigang Fang, vice president of Peking University Health Science Center and director of PUCRI, said, “In China, paper-based clinical trials are still mainstream, especially at Chinese domestic companies. By working with Medidata, we look forward to further advancing clinical development in the country, serving as a bridge between globally-leading technology and innovative drug development.”

Professor Yangfeng Wu, executive associate director of PUCRI, said, “The enhanced partnership between PUCRI and Medidata will provide better services and inject new vitality in drug development in China.”

Combining cloud-based solutions with experience in clinical development, Medidata and PUCRI have collaborated for several years to introduce innovative technology into clinical research in China. Together, they are helping life sciences companies improve operational efficiencies and increase productivity across China’s clinical research programs. Medidata and PUCRI will provide life sciences companies in China with increased accessibility to technology that streamlines clinical trials and, ultimately, helps to accelerate the delivery of novel therapies to patients.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing